Search - tctmd.com

Displaying 641 - 660 of 1063

Sort: Relevancy | Date

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

Michael O'Riordan

February 09, 2018

News Daily News

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Yael L. Maxwell

February 06, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Women Have Higher Risk of Unplanned Readmission After PCI

Michael O'Riordan

January 12, 2018

News Industry News

Positive Five-Year Data Published for MiStent in EuroIntervention

January 12, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Yael L. Maxwell

January 04, 2018

News Daily News

Spending More Won’t Necessarily Improve Acute MI Outcomes

Todd Neale

December 22, 2017

News Daily News

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

Todd Neale

December 20, 2017

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Caitlin E. Cox

December 05, 2017

News Daily News

FDA Approves EluNIR Drug-Eluting Stent

Michael O'Riordan

November 30, 2017

News Industry News

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

November 30, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Advertisement

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

SELUTION™ First-in-Man Study Achieves Primary Endpoint

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Women Have Higher Risk of Unplanned Readmission After PCI

Positive Five-Year Data Published for MiStent in EuroIntervention

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Spending More Won’t Necessarily Improve Acute MI Outcomes

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

FDA Approves EluNIR Drug-Eluting Stent

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content